Literature DB >> 4247956

Immunological evidence for human myosin isoenzymes.

U Gröschel-Stewart, D Doniach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4247956      PMCID： PMC1456031     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  17 in total

1.  Serum autoantibodies in myasthenia gravis and thymoma: selective affinity for I-bands of striated muscle as a guide to identification of antigen(s).

Authors:  A J Strauss; P G Kemp
Journal:  J Immunol       Date:  1967-11       Impact factor: 5.422

2.  Direct fluorescent antibody studies of gamma globulin localization in muscle of patients with myasthenia gravis.

Authors:  E H Beutner; G Fazekas; A Scott; E Witebsky
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

3.  Antibodies against the various types of skeletal muscle fibres.

Authors:  T E Feltkamp; T M Feltkamp-Vroom
Journal:  Immunology       Date:  1965-09       Impact factor: 7.397

4.  Studies on myosin from red and white skeletal muscles of the rabbit. I. Adenosine triphosphatase activity.

Authors:  F A Sreter; J C Seidel; J Gergely
Journal:  J Biol Chem       Date:  1966-12-25       Impact factor: 5.157

5.  An immunochemical comparison of myosin from canine heart and skeletal muscle.

Authors:  A C Fox; M D Klein
Journal:  Biochim Biophys Acta       Date:  1966-09-26

6.  Immunochemical studies on myosin. IV. Immunochemical comparison of rabbit and chicken skeletal muscle myosins.

Authors:  H Finck
Journal:  Biochim Biophys Acta       Date:  1965-11-15

7.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

8.  Antibody to smooth muscle in patients with liver disease.

Authors:  G D Johnson; E J Holborow; L E Glynn
Journal:  Lancet       Date:  1965-10-30       Impact factor: 79.321

9.  Myasthenia gravis and humoral antibodies against human skeletal muscle proteins.

Authors:  D Ricken
Journal:  Ger Med Mon       Date:  1966-04

10.  ATPase activity of myosin correlated with speed of muscle shortening.

Authors:  M Bárány
Journal:  J Gen Physiol       Date:  1967-07       Impact factor: 4.086
View more
  8 in total

1.  Histochemical and immunochemical studies on mammalian striated muscle fibres.

Authors:  U Gröschel-Stewart; K Meschede; I Lehr
Journal:  Histochemie       Date:  1973

2.  [Enzymatic differences between myosin-ATPases in striated muscles of rabbits].

Authors:  K Büchi; E Jenny
Journal:  Experientia       Date:  1971-12-15

3.  "Groundsubstance" resembling amyloid extracted from the cervical portion of human cervix uteri.

Authors:  U Gröschel-Stewart; U Hermann; H Schwalm
Journal:  Br J Exp Pathol       Date:  1973-04

4.  Myosin autoantibodies detected by immunofluorescence.

Authors:  A J Fairfax; U Gröschel-Stewart
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

5.  Production of specific antibodies to contractile proteins, and their use in immunofluorescence microscopy. I. Antibodies to smooth and striated chicken muscle myosins.

Authors:  U Gröschel-Stewart; J Schreiber; C Mahlmeister
Journal:  Histochemistry       Date:  1976-02-26

6.  The size of the fibre populations in rabbit skeletal muscles as revealed by indirect immunofluorescence with anti-myosin sera.

Authors:  H Lutz; M Ermini; E Jenny
Journal:  Histochemistry       Date:  1978-09-15

7.  Polymorphism of myosin among skeletal muscle fiber types.

Authors:  G F Gauthier; S Lowey
Journal:  J Cell Biol       Date:  1977-09       Impact factor: 10.539

8.  Use of type-specific antimyosins to demonstrate the transformation of individual fibers in chronically stimulated rabbit fast muscles.

Authors:  N Rubinstein; K Mabuchi; F Pepe; S Salmons; J Gergely; F Sreter
Journal:  J Cell Biol       Date:  1978-10       Impact factor: 10.539
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.